Immunocore Holdings Plc (IMCR)
28.62
+0.82
(+2.97%)
USD |
NASDAQ |
Jun 09, 16:00
28.62
0.00 (0.00%)
After-Hours: 20:00
Immunocore Holdings Shareholders Equity (Quarterly) : 393.67M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Silence Therapeutics Plc | 49.40M |
| NuCana Plc | 29.50M |
| Mereo BioPharma Group Plc | 34.05M |
| Compass Pathways Plc | 326.69M |
| Genflow Biosciences Plc | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.072B |
| Total Liabilities (Quarterly) | 678.42M |
| Debt to Equity Ratio | 1.107 |
| Current Ratio | 4.181 |
| Net Debt Paydown Yield | -0.04% |